Dr. Poorya Amini, Risklick · GlobeNewswire Inc. NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Citeline, a leader in clinical solutions for the life sciences industry, and Risklick, a Swiss-based company ...

BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, today announced new capabilities ...

The use of Artificial Intelligence (AI) and Machine Learning (ML) in clinical research is rapidly evolving, offering a glimpse into a future where medical innovation is driven by data-driven ...

Clinical trials are increasing in complexity at the same time as clinical development teams are being tasked with doing more with less. This panel of experts address why and how protocol complexity ...

There is a great need to develop, standardize, assess, and validate clinical protocols and standard operating procedures for vascularized composite allotransplantation transplants, with the goal of ...

Clinical development is undergoing a structural shift. Protocols are growing more complex, budgets are shrinking, and expectations from regulators, payers, and patients continue to rise. Meanwhile, ...

Healthcare providers working in integrative, functional and conventional medicine face a complex challenge: how to recommend high-quality supplements while maintaining clinical rigor and efficiency.

When discussing the future of clinical trials, people often focus on the promise of exciting new technologies, including artificial intelligence (AI) and predictive modeling. However, even the most ...

As clinical development grows more complex, sponsors are rethinking how outsourcing models, technology, and partnerships align to support both speed and sustainability. The shift toward hybrid models, ...

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Citeline, a leader in clinical solutions for the life sciences industry, and Risklick, a Swiss-based company specializing in AI-driven solutions for ...